David Julius Probes the Molecular Mechanics of Pain

For nearly 30 years, the UC San Francisco researcher has delved into unexplored corners of the nervous system.

Written byAnna Azvolinsky
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

David Julius
Professor and Chair, Department of Physiology, University of California, San Francisco,
School of Medicine 2010 Shaw Prize in Life Sciences and Medicine 2013 Paul Janssen Prize for Biomedical Research 2017 Canada Gairdner International Award
SUSAN MERRILL, UCSF
David Julius entered the biochemistry graduate program at the University of California, Berkeley, in 1977. “It was all one foot in front of the other. I wasn’t trying to figure out what I would be doing in 10 years,” says the University of California, San Francisco (UCSF) professor of physiology. “When I arrived, I thought, ‘Classes are pretty much over. This is like a real job, and I can just go in the lab and do my thing.’”

Julius joined the UC Berkeley lab of Jeremy Thorner, who was studying hormonal signaling and trying to understand how budding yeast cells switch mating type. Randy Schekman, a Berkeley researcher who worked on protein secretion and vesicular transport, served as Julius’s coadvisor. “What was great about Jeremy and Randy was that they were both trained as biochemists and then had decided to take advantage of the yeast genetic system to understand the biochemistry of cellular signaling.”

Haploid yeast cells can be either “type a” or “type α,” and mate with cells of the opposite type. Julius worked on the synthesis of alpha factor, one of two mating hormones produced and secreted by yeast. His graduate studies produced three Cell papers. The first, published in 1983, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile

Published In

January 2018

The Science of Pain

New research on an age-old ailment

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies